Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04675255 · ClinicalTrials.gov registry record · NA
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT04675255 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 8 participants.
The verdict
NCT04675255, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A substudy of TMC114FD2HTX4004 that will perform glucose tolerance testing, adipose testing and MRI scan at baseline, 12 and 24 weeks post switch of ART medications.
Interventions
- PROCEDURE Frequently sampled glucose tolerance testing
- PROCEDURE abdominal subcutaneous adipose tissue biopsy
- PROCEDURE MRI scan to assess intrahepatic triglyceride content
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2023-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04675255
The ClinicalTrials.gov registry entry for NCT04675255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Frequently sampled glucose tolerance testing is the first listed.
NCT04675255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04675255 about?
NCT04675255 is a clinical study titled "Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism". A substudy of TMC114FD2HTX4004 that will perform glucose tolerance testing, adipose testing and MRI scan at baseline, 12 and 24 weeks post switch of ART medications.
What is the current status of trial NCT04675255?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2021-01-01. Estimated completion is 2023-06-08.
What interventions are being tested in trial NCT04675255?
The interventions under investigation include: Frequently sampled glucose tolerance testing (PROCEDURE), abdominal subcutaneous adipose tissue biopsy (PROCEDURE), MRI scan to assess intrahepatic triglyceride content (PROCEDURE).
Who is sponsoring clinical trial NCT04675255?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.